PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
The complexity of eukaryotic gene regulation is slowly being resolved. What has become clear is that transcriptional regulation is a multi-step process that involves the assembly of macromolecular complexes. This review will discuss the biology of the ETS family transcription factor PU.1, with emphasis on its interactions with two members of the Interferon Regulatory Factor (IRF) family, interferon consensus sequence binding protein (ICSBP), and IRF-4. The role of these interactions in transcriptional regulation is discussed, with respect to DNA binding motifs, protein-protein interaction and phosphorylation states that modulate PU.1/IRF interactions. Furthermore, potential transcriptional mechanisms for several genes are discussed, focusing on genes involved in innate immunity. Data from these studies suggest at least four distinct paradigms for transcriptional regulation by an ETS protein in conjunction with either ICSBP or IRF-4. These paradigms may describe regulatory mechanisms common to many distinct transcription factor families. Last, recent data from several laboratories have now documented the expression of ICSBP and IRF-4 in a range of cell types. These data suggest that ICSBP and IRF-4 may serve functions within these cell types that are distinct from their previously recognized functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip/NF-EM5/IRF-4, a member of IRF family, is a lymphoid-restricted transcription factor that is recruited to a composite element (IRF/ETS-binding site) within Ig light chain enhancers through a specific interaction with PU.1 protein [116, 117].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [116]
Citations
Cites
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932 · cited 4×
“A typical single-copy ISRE follows the consensus sequence 5′ GAAANT/C 3′; the GAS element consensus is 5′ TTTNCNNNAA 3′ (50,56).”
BackgroundInfluentialRequirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“However, these mice do possess megakaryocytes, immature mast cells, and erythroid cells (24), which suggests that PU.”
BackgroundTargeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 958 · cited 2×
“IRF-1 is generally believed to function as a transcriptional activator (61).”
BackgroundLin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915 · cited 1×
“IRFs 1–3 are phosphorylated by CK2, and ICSBP and IRF-4 contain multiple potential CK2 consensus sites that follow the consensus /TXX/E motif (107,108,119).”
BackgroundThe Ets family of transcription factors
WASYLYK, B., HAHN, S. L., & GIOVANE, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 842 · cited 1×
“ETS family members recognize, and bind via the ETS domain, to a core RGAA DNA motif centered within a longer nucleotide sequence (9,10).”
BackgroundRegulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644 · cited 1×
“As expected, these mice also displayed impaired responses against pathogens that require functional macrophages for host immunity, specifically Listeria monocytogenes and lymphocytic choriomeningitis virus (LCMV) (84,85).”
BackgroundRequirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté, M., Servant, M. J., LePage, C., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 562 · cited 1×
“Some IRF proteins also contain a putative IRF-association domain (IAD) within the carboxy-terminus, through which protein–protein interactions with IRF and non-IRF proteins are believed to occur (56,57).”
BackgroundOsteopetrosis in mice lacking haematopoietic transcription factor PU.1
Tondravi, M. M., McKercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M., Maki, R., & Teitelbaum, S. L. (1997) · Nature · doi:10.1038/386081a0 · Cited by 539 · cited 1×
“1 knock-out mice also developed osteopetrosis (43).”
The growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480 · cited 6×
“Some IRF proteins also contain a putative IRF-association domain (IAD) within the carboxy-terminus, through which protein–protein interactions with IRF and non-IRF proteins are believed to occur (56,57).”
BackgroundInfluentialPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447 · cited 2×
“1, and the interferon regulatory factor (IRF) family members interferon consensus sequence binding protein (ICSBP) and interferon regulatory factor 4 (IRF-4) are expressed in a tissue-specific manner (1,2).”
BackgroundZhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
Escalante, C. R., Yie, J., Thanos, D., & Aggarwal, A. K. (1998) · Nature · doi:10.1038/34224 · Cited by 397 · cited 2×
“Several studies suggest that this DBD forms a wHTH structure (68,69).”
BackgroundAu, W. C., Moore, P. A., Lowther, W., Juang, Y. T., & Pitha, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11657 · Cited by 388
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356 · cited 1×
“1, and the interferon regulatory factor (IRF) family members interferon consensus sequence binding protein (ICSBP) and interferon regulatory factor 4 (IRF-4) are expressed in a tissue-specific manner (1,2).”
BackgroundPongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354 · cited 15×
“As noted above, PU.1 can also interact with the IRF family members ICSBP and IRF-4 (6,7,17).”
BackgroundInfluentialFujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y., & Taniguchi, T. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03213.x · Cited by 347
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
Iida, S., Rao, P. H., Butler, M., Corradini, P., Boccadoro, M., Klein, B., Chaganti, R. S. K., & Dalla-Favera, R. (1997) · Nature Genetics · doi:10.1038/ng1097-226 · Cited by 337 · cited 1×
“nomenon is thought to correlate with onset and development of multiple myeloma (94).”
BackgroundA new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex
Kodandapani, R., Pio, F., Ni, C.-Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R. A., & Ely, K. R. (1996) · Nature · doi:10.1038/380456a0 · Cited by 315
Hagemeier, C., Bannister, A. J., Cook, A., & Kouzarides, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1580 · Cited by 303
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301 · cited 5×
“The negative regulation of CD11c is of particular interest because PU.1 is a critical factor in the activation of a related β-integrin gene, namely CD11b (27).”
BackgroundInfluentialRegulation of Type I Interferon Gene Expression by Interferon Regulatory Factor-3
Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J., & Pitha, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2714 · Cited by 272
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 271 · cited 15×
“As noted above, PU.1 can also interact with the IRF family members ICSBP and IRF-4 (6,7,17).”
BackgroundInfluentialSearles, R. P., Bergquam, E. P., Axthelm, M. K., & Wong, S. W. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3040-3053.1999 · Cited by 264
John, S., Reeves, R. B., Lin, J.-X., Child, R., Leiden, J. M., Thompson, C. B., & Leonard, W. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1786 · Cited by 248
Sirover, M. A. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970801)66:2<133::aid-jcb1>3.0.co;2-r · Cited by 243
Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R. (1993) · Science · doi:10.1126/science.8316859 · Cited by 222
Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A., & Ozato, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1523 · Cited by 217 · cited 1×
“As expected, these mice also displayed impaired responses against pathogens that require functional macrophages for host immunity, specifically Listeria monocytogenes and lymphocytic choriomeningitis virus (LCMV) (84,85).”
BackgroundInduction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis
Fenton, M. J., Vermeulen, M. W., Kim, S., Burdick, M., Strieter, R. M., & Kornfeld, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5149-5156.1997 · Cited by 214 · cited 1×
“IFN-γ, also termed type II IFN, is produced predominantly by CD4+T cells and NK cells, but macrophages can also produce detectable quantities (51,52).”
BackgroundSelf-citationBrass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 204 · cited 1×
“1 and IRF-4 DBDs, connected by a flexible linker, inhibited Ig λ light chain enhancer expression in B cells, implying in vivo binding of this element (110).”
BackgroundLack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias
Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199
Rel Induces Interferon Regulatory Factor 4 (IRF-4) Expression in Lymphocytes
Grumont, R. J., & Gerondakis, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1281 · Cited by 198
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 196 · cited 3×
“in macrophages remain to be defined (54).”
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196 · cited 6×
“For example, both ICSBP and IRF-4 function as repressors when bound to ISRE elements (53,74).”
BackgroundInfluentialMyeloid Development Is Selectively Disrupted in PU.1 Null Mice
Anderson, K. L., Smith, K. A., Conners, K., McKercher, S. R., Maki, R. A., & Torbett, B. E. (1998) · Blood · doi:10.1182/blood.v91.10.3702 · Cited by 193
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588-599.1993 · Cited by 192 · cited 2×
“For example, both ICSBP and IRF-4 function as repressors when bound to ISRE elements (53,74).”
BackgroundActivation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
Vaughan, P. S., Aziz, F., van Wijnen, A. J., Wu, S., Harada, H., Taniguchi, T., Soprano, K. J., Stein, J. L., & Stein, G. S. (1995) · Nature · doi:10.1038/377362a0 · Cited by 189
Spi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189 · cited 1×
“Approximately half of these animals developed multistep erythroleukemias and died within one month of disease onset (44).”
BackgroundWang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
Eklund, E. A., Jalava, A., & Kakar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13957 · Cited by 176
Bovolenta, C., Driggers, P. H., Marks, M. S., Medin, J. A., Politis, A. D., Vogel, S. N., Levy, D. E., Sakaguchi, K., Appella, E., & Coligan, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5046 · Cited by 167
Induction of IFN-γ in macrophages by lipopolysaccharide
Fultz, M. J., Barber, S. A., Dieffenbach, C. W., & Vogel, S. N. (1993) · International Immunology · doi:10.1093/intimm/5.11.1383 · Cited by 165 · cited 1×
“IFN-γ, also termed type II IFN, is produced predominantly by CD4+T cells and NK cells, but macrophages can also produce detectable quantities (51,52).”
BackgroundSharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162
Giese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160
Jesse, T. L., LaChance, R., Iademarco, M. F., & Dean, D. C. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.5.1265 · Cited by 159
Fisher, R. C., & Scott, E. W. (1998) · STEM CELLS · doi:10.1002/stem.160025 · Cited by 158 · cited 1×
“1 is expressed by macrophages, Bcells, neutrophils, and osteoclasts (11).”
BackgroundWeisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., & Levi, B. Z. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74081-2 · Cited by 152 · cited 1×
“Some of these genes include MHC-I (H-2Ld), 2′-5′-oligo-adenylate synthetase (OAS) and interferon-stimulated gene 54 (ISG54) (74,79,80).”
BackgroundThe transcription factor PU.1 is involved in macrophage proliferation.
Celada, A., Borràs, F. E., Soler, C., Lloberas, J., Klemsz, M., van Beveren, C., McKercher, S., & Maki, R. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.61 · Cited by 152 · cited 4×
“In some instances, binding of both factors to DNA is required; in others, PU.1 may actually tether another factor to the DNA, as has been reported for c-Jun on the M-CSF promoter and C/EBPβ on the IL-1β promoter (35,36).”
BackgroundInfluentialKominato, Y., Galson, D. L., Waterman, W. R., Webb, A. C., & Auron, P. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.59 · Cited by 151
Westermarck, J. K., Seth, A. K., & Kähäri, V. (1997) · Oncogene · doi:10.1038/sj.onc.1201111 · Cited by 149 · cited 2×
“1 has been reported to repress the I-Aβ MHC class II (37), interstitial collagenase MMP-I (38), and CD11c (39) genes.”
BackgroundMeraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
Takaoka, A., Tanaka, N., Mitani, Y., Miyazaki, T., Fujii, H., Sato, M., Kovarik, P., Decker, T., Schlessinger, J., & Taniguchi, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2480 · Cited by 145
ETS1, NFκB and AP1 synergistically transactivate the human GM – CSF promoter
Thomas, R. S., Tymms, M. J., McKinlay, L. H., Shannon, M. F., Seth, A. K., & Kola, I. (1997) · Oncogene · doi:10.1038/sj.onc.1201125 · Cited by 145
Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143 · cited 1×
“of Bcr-Abl-induced CML-like cells was decreased following expression of ICSBP (89).”
BackgroundBassuk, A. G., Anandappa, R. T., & Leiden, J. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3563-3573.1997 · Cited by 139 · cited 2×
“The regulation of some of these PU.1-dependent genes involves heterodimeric complexes of PU.1 with a variety of other transcription factors and co-activators, including C/EBPδ and HMG I/Y, NF-κB family members, IRF-4, and ICSBP (6,7,33,34).”
BackgroundGobin, S. J. P., van Zutphen, M., Woltman, A. M., & van den Elsen, P. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1428 · Cited by 136
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burýšek, L., Yeow, W.-S., & Pitha, P. M. (1999) · PubMed · Cited by 126
Masumi, A., Wang, I.-M., Lefebvre, B., Yang, X.-J., Nakatani, Y., & Ozato, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1810 · Cited by 124
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M., Chen, H. M., & Simon, M. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.203 · Cited by 115 · cited 1×
“1 is most closely related to Spi-B, and the recently described SpiC, both of which are also highly restricted in their cellular expression patterns (19, 20).”
BackgroundPhysical and functional interactions between the transcription factor PU.1 and the coactivator CBP
Yamamoto, H., Kihara-Negishi, F., Yamada, T., Hashimoto, Y., & Oikawa, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202427 · Cited by 113 · cited 3×
“1 has been reported to interact with the histone acetylase CREB binding protein (CBP) (16), implicating PU.”
BackgroundInfluentialNagulapalli, S., Pongubala, J. M., & Atchison, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4330 · Cited by 110 · cited 2×
“The regulation of some of these PU.1-dependent genes involves heterodimeric complexes of PU.1 with a variety of other transcription factors and co-activators, including C/EBPδ and HMG I/Y, NF-κB family members, IRF-4, and ICSBP (6,7,33,34).”
BackgroundSpi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110 · cited 1×
“ETS family members recognize, and bind via the ETS domain, to a core RGAA DNA motif centered within a longer nucleotide sequence (9,10).”
BackgroundLodie, T. A., Savedra, R., Golenbock, D. T., Van Beveren, C. P., Maki, R. A., & Fenton, M. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1848 · Cited by 106
Self-citationRoles of IFN Consensus Sequence Binding Protein and PU.1 in Regulating IL-18 Gene Expression
Kim, Y.-M., Kang, H.-S., Paik, S.-G., Pyun, K.-H., Anderson, K. L., Torbett, B. E., & Choi, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2000 · Cited by 104 · cited 1×
“Potential composite sites are also present within the IL-1β, IL-18, and macrophage scavenger receptor promoters (31,82,83).”
BackgroundLau, J. F., Parisien, J.-P., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7278 · Cited by 104
Suzuki, S., Kumatori, A., Haagen, I.-A., Fujii, Y., Sadat, M. A., Jun, H. L., Tsuji, Y., Roos, D., & Nakamura, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6085 · Cited by 102
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100 · cited 1×
“In contrast to these interactions, weak interactions between ICSBP and ISGF3γ were found to inhibit binding of ISGF3γ to a GAS element (100).”
BackgroundSzymczyna, B. R., & Arrowsmith, C. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004294200 · Cited by 99
NF-IL6 (C/EBPβ) Vigorously Activates il1b Gene Expression via a Spi-1 (PU.1) Protein-Protein Tether
Yang, Z., Wara-aswapati, N., Chen, C., Tsukada, J., & Auron, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000145200 · Cited by 92 · cited 1×
“1 may actually tether another factor to the DNA, as has been reported for c-Jun on the M-CSF promoter and C/EBPβ on the IL-1β promoter (35,36).”
BackgroundA role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity
Lin, R., & Hiscott, J. B. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006850009017 · Cited by 88 · cited 2×
“Nonetheless, IRF-1, IRF-2, and IRF-3 can be phosphorylated by protein kinase CK2, which suggests a role for CK2 in IRF function (56,107,108).”
BackgroundMarecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
Self-citationPU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86 · cited 1×
“1 is not required for synergistic activation of the Ig κ enhancer with IRF-4 (49).”
BackgroundMoulton, K. S., Semple, K., Wu, H., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4408 · Cited by 86 · cited 1×
“Potential composite sites are also present within the IL-1β, IL-18, and macrophage scavenger receptor promoters (31,82,83).”
BackgroundYabu, T., Hirose, H., Hırono, I., Katagiri, T., Aoki, T., & Yamamoto, E. (1998) · PubMed · Cited by 83
Pio, F., Kodandapani, R., Ni, C.-Z., Shepard, W., Klemsz, M., McKercher, S. R., Maki, R. A., & Ely, K. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23329 · Cited by 81 · cited 3×
“1 ETS domain exists as a variation of this form, existing as a winged loop-helix-loop (in contrast to a helix-loop-helix) when bound to DNA (21,22).”
BackgroundTsukada, J., Waterman, W. R., Koyama, Y., Webb, A. C., & Auron, P. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2183 · Cited by 78 · cited 1×
“1 binding site and maps to a site previously shown to regulate human IL-1β transcription in response to LPS and cytokines (115).”
BackgroundA Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
Contursi, C., Wang, I.-M., Gabriele, L., Gadina, M., O'Shea, J., Morse, H. C., & Ozato, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.91 · Cited by 72
Politis, A. D., Sivo, J., Driggers, P. H., Ozato, K., & Vogel, S. N. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.3.801 · Cited by 68 · cited 1×
“IRF-4 expression does not appear to be modulated by IFN-γ stimulation, whereas ICSBP expression is strongly induced (53,77).”
BackgroundHimmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 68 · cited 1×
“1 could interact with ICSBP at a composite element present within the CD20 promoter to weakly activate CD20 expression in B cells (8).”
BackgroundInterferon Regulatory Factor-2 Directs Transcription from the gp91 Promoter
Luo, W., & Skalnik, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23445 · Cited by 67
Regulation of IFN Consensus Sequence Binding Protein Expression in Murine Macrophages
Kantakamalakul, W., Politis, A. D., Marecki, S., Sullivan, T., Ozato, K., Fenton, M. J., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7417 · Cited by 61
Self-citationPolitis, A. D., Ozato, K., Coligan, J. E., & Vogel, S. N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.5.2270 · Cited by 61
Grossman, A., Mittrücker, H.-W., Nicholl, J., Suzuki, A., Chung, S., Antonio, L., Suggs, S., Sutherland, G. R., Siderovski, D. P., & Mak, T. W. (1996) · Genomics · doi:10.1006/geno.1996.0547 · Cited by 60 · cited 2×
“Previous names include NF-EM5, PU.1-interaction partner, lymphocyte-specific IRF (LSIRF) and ICSAT (6,7,53,54,90).”
The [(G/C)3NN]n motif: a common DNA repeat that excludes nucleosomes.
Wang, Y. H., & Griffith, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8863 · Cited by 55 · cited 1×
“The ETS core may, by itself, exclude histone proteins because of this intrinsic bending (96).”
BackgroundSpi-C, a Novel Ets Protein That Is Temporally Regulated during B Lymphocyte Development
Bemark, M., Mårtensson, A., Liberg, D., & Leanderson, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10259 · Cited by 53 · cited 1×
“1 is most closely related to Spi-B, and the recently described SpiC, both of which are also highly restricted in their cellular expression patterns (19, 20).”
BackgroundCommitment to the Monocytic Lineage Occurs in the Absence of the Transcription Factor PU.1
Henkel, G. W., McKercher, S. R., Leenen, P. J. M., & Maki, R. A. (1999) · Blood · doi:10.1182/blood.v93.9.2849 · Cited by 53
ETS Protein–Dependent Accessibility Changes at the Immunoglobulin μ Heavy Chain Enhancer
Nikolajczyk, B. S., Sanchez, J. A., & Sen, R. (1999) · Immunity · doi:10.1016/s1074-7613(00)80077-1 · Cited by 51 · cited 1×
“1 increased chromatin accessibility in vitro and in vivo (97).”
BackgroundIFN consenus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters
Welsz, A., Kirchhoff, S., & Levi, B.-Z. (1994) · International Immunology · doi:10.1093/intimm/6.8.1125 · Cited by 50 · cited 1×
“Some of these genes include MHC-I (H-2Ld), 2′-5′-oligo-adenylate synthetase (OAS) and interferon-stimulated gene 54 (ISG54) (74,79,80).”
BackgroundFisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49 · cited 2×
“demonstrated that serines 132 and 133, but not Ser-148, are required for myeloid cell development (45).”
BackgroundRao, S., Matsumura, A., Yoon, J., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11115 · Cited by 47 · cited 2×
“1, can interact with both IRF-4 and ICSBP in B cells (102,138).”
BackgroundOrtiz, M. A., Light, J., Maki, R. A., & Assa-Munt, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2740 · Cited by 44
DNA Methylation and Chromatin Structure Regulate PU.1 Expression
Amaravadi, L., & Klemsz, M. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314737 · Cited by 44 · cited 1×
“1 expression is regulated via DNA methylation and at the level of chromatin (18).”
BackgroundCheng, G., NAZAR, A. S. M. I., Shin, H. S., Vanguri, P., & Shin, M. L. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.987 · Cited by 42 · cited 1×
“suggest that the ISRE motif and NF-κB elements present at distant sites within this promoter worked cooperatively to activate gene expression (118).”
BackgroundRepression of I-Aβ Gene Expression by the Transcription Factor PU.1
Borràs, F. E., LLoberas, J., Maki, R. A., & Celada, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24385 · Cited by 41 · cited 1×
“1 has been reported to repress the I-Aβ MHC class II (37), interstitial collagenase MMP-I (38), and CD11c (39) genes.”
BackgroundLópez‐Rodríguez, C., & Corbí, A. L. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270804 · Cited by 40 · cited 3×
“1 has been reported to repress the I-Aβ MHC class II (37), interstitial collagenase MMP-I (38), and CD11c (39) genes.”
BackgroundLodie, T. A., Reiner, M., Coniglio, S. J., Viglianti, G. A., & Fenton, M. J. (1998) · PubMed · Cited by 39
Self-citationBuras, J. A., Monks, B. G., & Fenton, M. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4444 · Cited by 39
Self-citationCooperative interaction between the DNA-binding domains of PU.1 and IRF4
Yee, A. A., Yin, P., Siderovski, D. P., Mak, T. W., Litchfield, D. W., & Arrowsmith, C. H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1838 · Cited by 38
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38 · cited 15×
“As noted above, PU.1 can also interact with the IRF family members ICSBP and IRF-4 (6,7,17).”
BackgroundInfluentialRole of Asymmetric Phosphate Neutralization in DNA Bending by PU.1
Strauss-Soukup, J. K., & Maher, L. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31570 · Cited by 31
PU.1 and USF Are Required for Macrophage-specific Mannose Receptor Promoter Activity
Egan, B. S., Lane, K. B., & Shepherd, V. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9098 · Cited by 31
Li, W., Nagineni, C. N., Ge, H., Efiok, B., Chepelinsky, A. B., & Egwuagu, C. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9686 · Cited by 29 · cited 1×
“have also demonstrated the expression of functional ICSBP in retinal epithelia and ocular lens (75,76).”
BackgroundLi, W., Nagineni, C. N., Hooks, J. J., Chepelinsky, A. B., & Egwuagu, C. E. (1999) · PubMed · Cited by 27
Furui, J., Uegaki, K., Yamazaki, T., Shirakawa, M., Swindells, M. B., Harada, H., Taniguchi, T., & Kyogoku, Y. (1998) · Structure · doi:10.1016/s0969-2126(98)00050-1 · Cited by 27 · cited 2×
“Several studies suggest that this DBD forms a wHTH structure (68,69).”
BackgroundGupta, S. K., Xia, D., Jiang, M., Lee, S.-J., & Pernis, A. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5997 · Cited by 27 · cited 1×
“has demonstrated that the GAS element present within the IRF-1 promoter can be inducibly occupied by either STAT proteins or NF-κB family members, depending on the activating stimulus (106).”
BackgroundBirnbaum, M. J., van Zundert, B., Vaughan, P. S., Whitmarsh, A. J., van Wijnen, A. J., Davis, R. J., Stein, G. S., & Stein, J. L. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970801)66:2<175::aid-jcb5>3.0.co;2-n · Cited by 27
Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation
Nguyen, H., Teskey, L., Lin, R., & Hiscott, J. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202924 · Cited by 26 · cited 1×
“suggest that IRF-1 can also function as a transcriptional repressor (62).”
BackgroundInaba, T., Gotoda, T., Ishibashi, S., Harada, K., Ohsuga, J.-I., Ohashi, K., Yazaki, Y., & Yamada, N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2264 · Cited by 24
Buras, J. A., Reenstra, W. R., & Fenton, M. J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00018-a · Cited by 23
Self-citationGross, P., Yee, A. A., Arrowsmith, C. H., & Macgregor, R. B. (1998) · Biochemistry · doi:10.1021/bi9731448 · Cited by 23 · cited 1×
“1 and IRF-4 DBDs both bound to the major groove of DNA, with additional protein–protein interactions occurring near the minor groove (113).”
BackgroundIn vivo formation of IRF-1 homodimers
Kirchhoff, S., Schaper, F., Oumard, A., & Häuser, H. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80019-4 · Cited by 20 · cited 1×
“demonstrated that IRF-1 is capable of forming homodimers in living cells via DBD interactions, rather than via IRF-association domain interactions (70).”
Background
Cited by
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G., Xiao, W., Powell, J., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 521
“Remarkably, survival of ABC DLBCL cells depended on a single amino acid in IRF4 that mediates its interaction with SPIB on composite EICE motifs.”
BackgroundInfluentialInterferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis
Zhao, B., Takami, M., Yamada, A., Wang, X., Koga, T., Hu, X., Tamura, T., Ozato, K., Choi, Y., Ivashkiv, L. B., et al. (2009) · Nature Medicine · doi:10.1038/nm.2007 · Cited by 292
Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
“other key transcription factors, such as interferon regulatory factor (IRF)4, IRF8, AML-1, CCAAT/enhancer binding protein (C/EBP ), GATA-1, and c-Jun (13).”
BackgroundToll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System
Ozato, K., Tsujimura, H., & Tamura, T. (2002) · BioTechniques · doi:10.2144/oct0208 · Cited by 189
Metadata
- Authors
- Marecki, S., & Fenton, M. J.
- Affiliations
- Boston University (US)
- ORCID
- Fenton, Matthew J.
- Venue
- Cell Biochemistry and Biophysics
- Published
- 2000
- Volume
- 33
- Issue
- 2
- Pages
- 127-148
- ISSN
- 1085-9195 (ISSN-L)
- OpenAlex
- W2330690422
- Semantic Scholar
- 1f32d4a50efbfa831a0783908370cea0e52d57cd
- Cited by
- 74
- References
- 117
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 3
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell Biochemistry and Biophysics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- PU.1, interferon regulatory factors, IRF8, IRF4, ETS transcription factors, transcriptional regulation, protein-protein interaction, phosphorylation, DNA-binding motifs, innate immunity, transcription factor complex
- MeSH terms
- Interferon Regulatory Factor-8, Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Animals, Binding Sites, DNA, DNA-Binding Proteins, Gene Expression Regulation, Humans, Interferons, Proto-Oncogene Proteins, Repetitive Sequences, Nucleic Acid, Repressor Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Consensus Sequence, Proto-Oncogene Proteins c-ets, Interferon Regulatory Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.